Dotagraf 60 (Gadoteric acid Ampoules) 16.76g/60ml

Dotagraf 60 contains gadoteric acid, a contrast agent in ampoules for MRI procedures. Used to enhance imaging clarity in soft tissues and vascular structures. Supplied as 16.76g/60ml in single-dose ampoules. Store between 2-8°C to maintain stability.

Strength

16.76g/60ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Berlis AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dotagraf 60 is a gadolinium-based contrast agent primarily used to improve the visibility of internal body structures during magnetic resonance imaging (MRI) scans. It helps radiologists detect abnormalities in organs, blood vessels, and soft tissues by enhancing contrast in images. Commonly used for brain, spinal cord, and musculoskeletal imaging.

Side Effects

After administration, Dotagraf 60 works by temporarily altering the magnetic properties of nearby tissues, making them appear brighter on MRI scans. Patients may experience a brief sensation of warmth or mild discomfort at the injection site. Effects are transient and typically resolve shortly after the procedure.

Precautions & Warnings

Dotagraf 60 should only be handled by healthcare professionals trained in MRI contrast administration. Ensure proper storage at 2-8°C and protect from light until use. Inspect ampoules for damage or particulate matter before administration. Discard any unused portion as it is for single use only.

Avoid Interactions

No known direct drug interactions have been established with Dotagraf 60. However, caution is advised when used with other medications affecting renal function or gadolinium-based agents. Patients with severe kidney disease should consult their healthcare provider before administration.

Frequently Asked Questions

Dotagraf 60 is a contrast agent used to enhance MRI images for better visualization of soft tissues and blood vessels.

It is administered via intravenous injection by a healthcare professional during an MRI procedure.

Patients with severe kidney disease should consult their doctor before use due to potential risks.

Dotagraf 60 must be stored between 2-8°C and protected from light until use.

Safety depends on individual health conditions; always consult a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.